Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Malignant Solid Tumors 1

Interventions

Specimen Handling 449Magnetic Resonance Spectroscopy 344pembrolizumab 296Biopsy 247Carboplatin 235Cisplatin 198Cyclophosphamide 190Paclitaxel 167Nivolumab 158Gemcitabine 154Bevacizumab 125Radiotherapy 122Dexamethasone 115fludarabine 102Pemetrexed 102Fluorouracil 96Doxorubicin 92venetoclax 91durvalumab 91Radiation 91Docetaxel 91atezolizumab 90Oxaliplatin 89Rituximab 88Leucovorin 82Capecitabine 78Prednisone 77Lenalidomide 71Etoposide 69X-Rays 67

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Premedication × 30 days × Clear all
NCT06573294 2026-05-20

Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors

Genmab

Phase 1 Terminated
23 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡